BOSTON MEDICAL CENTER CORPORATION

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 15152
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 12243
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 9197
 
  
 
C07K PEPTIDES 8128
 
  
 
A61B DIAGNOSIS; SURGERY; IDENTIFICATION 5235
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 4121
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 297
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 297
 
  
 
G01R MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES 2157
 
  
 
G01V GEOPHYSICS; GRAVITATIONAL MEASUREMENTS; DETECTING MASSES OR OBJECTS; TAGS 278

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0043,066 MACROINITIATORS FOR HYDROPHILIC COATINGS ON LATEX AND APPLICATIONS THEREOFFeb 22, 16Feb 15, 18[C08J, C08F, A61L]
2017/0369,591 PREDICTIVE MARKER FOR TOPOISOMERASE I INHIBITORSMar 30, 17Dec 28, 17[C07H, G01N, C07K]
2017/0089,997 AQUEOUS CONTRAST AGENTS FOR DYNAMIC MRI AND MRAMay 14, 15Mar 30, 17[A61B, G01R]
2016/0000,413 OPTICALLY AUGMENTED FINE NEEDLE ASPIRATION BIOPSY DEVICE AND METHOD OF USING THE SAMEJan 30, 14Jan 07, 16[A61B]
2015/0329,870 Methods for Elevating Fat/Oil Content in PlantsDec 19, 13Nov 19, 15[C12N, C07K]
2015/0297,316 TISSUE MARKERS AND USES THEREOFNov 21, 13Oct 22, 15[A61B, A61M]
2015/0004,703 SINGLE LENTIVIRAL VECTOR SYSTEM FOR INDUCED PLURIPOTENT (IPS) STEM CELLS DERIVATIONSep 15, 14Jan 01, 15[C12N]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9919009 Production of red blood cells and platelets from stem cellsJun 02, 15Mar 20, 18[A61K, C12N, G01N]
9896660 Production of red blood cells and platelets from stem cellsAug 15, 13Feb 20, 18[A61K, C12N, G01N]
9644036 Predictive marker for topoisomerase I inhibitorsFeb 19, 15May 09, 17[A61K, C07H, G01N, C07K]
9617325 Treatment of IgE-mediated diseaseDec 29, 14Apr 11, 17[A61K, C12P, C12N, C07K]
9599605 Parkinson's disease model and methodsMar 14, 14Mar 21, 17[C12Q, C12N, G01N, A01K]
9572879 ROBO2 inhibitory compositions comprising SLIT2-binding extracellular domain of ROBO2Jan 04, 13Feb 21, 17[A61K, C12Q, C12N, G01N, A61P, C07K]
9074186 Production of red blood cells and platelets from stem cellsMar 14, 13Jul 07, 15[A61K, C12N]
8993309 Predictive marker for topoisomerase I inhibitorsMar 31, 09Mar 31, 15[G01N]
8945575 Treatment of IgE-mediated diseaseDec 01, 10Feb 03, 15[A61K, C12P, C12N, C07K]
8865467 Single lentiviral vector system for induced pluripotent (iPS) stem cells derivationApr 06, 11Oct 21, 14[A01N, C12N]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2015/0285,789 ASSAYS, SYSTEMS, AND METHODS FOR OBTAINING PERSONALIZED ANABOLIC PROFILESAbandonedAug 20, 13Oct 08, 15[A61K, C12N, G01N, G06F]
2014/0363,464 PRE- OR POST-EXPOSURE TREATMENT FOR FILOVIRUS OR ARENAVIRUS INFECTIONAbandonedJun 25, 14Dec 11, 14[A61K, C12N]
2014/0255,444 COMPOSITIONS AND METHODS FOR TREATING EBOLA VIRUS INFECTIONAbandonedApr 02, 14Sep 11, 14[A61K]
2014/0179,549 METHODS FOR IDENTIFYING INFLAMMATORY BOWEL DISEASE PATIENTS WITH DYSPLASIA OR CANCERAbandonedDec 10, 13Jun 26, 14[C12Q]
2012/0214,169 DIFFERENTIAL LEVELS OF HAPTOGLODIN ISOFORMS IN SMALL CELL LUNG CANCERAbandonedFeb 21, 12Aug 23, 12[C12Q, C12M, G01N]
2011/0217,328 COMPOSITIONS AND METHODS FOR TREATING EBOLA VIRUS INFECTIONAbandonedDec 17, 08Sep 08, 11[A61K, C12N, A61P]
2011/0060,188 LOW COST DISPOSABLE MEDICAL FORCEPS TO ENABLE A HOLLOW CENTRAL CHANNEL FOR VARIOUS FUNCTIONALITIESAbandonedMar 06, 09Mar 10, 11[A61B]
2010/0203,521 METHOD FOR BACTERIAL LYSISAbandonedApr 02, 08Aug 12, 10[C12Q, C12M]
2009/0326,384 Device With Integrated Multi-Fiber Optical Probe and Methods of UseAbandonedJul 18, 07Dec 31, 09[A61B]
2009/0291,883 COMBINATION OF AN IMMUNOSUPPRESSIVE AGENT AND NONSTEROIDAL ANTI -INFLAMMATORY DRUGS TO TREAT DISEASEAbandonedJul 16, 07Nov 26, 09[A61K]
7517667 Methods for promoting, inhibiting and detecting toxin entry into cellsExpiredAug 30, 05Apr 14, 09[A61K, C12Q, C12P]
2008/0182,795 Specific antagonists for glucose-depenent insulinotropic polypeptide (GIP)AbandonedMar 04, 08Jul 31, 08[A61K, C07K]
2008/0051,379 Compositions and Methods for the Treatment of Peripheral B-Cell NeoplasmsAbandonedDec 01, 05Feb 28, 08[A61K, A61P]
2007/0203,435 System And Method For Gait Synchronized Vibratory Stimulation Of The FeetAbandonedMar 28, 05Aug 30, 07[A61H]
2007/0072,927 NUTRITIONAL SUPPLEMENT FOR INCREASED ENERGY AND STAMINAAbandonedAug 10, 06Mar 29, 07[A61K]
7091183 Specific antagonists for glucose-dependent insulinotropic polypeptide (GIP)ExpiredDec 03, 97Aug 15, 06[A61K]
2006/0167,238 Gene expression using metal ion dependent repressor/operator tandemsAbandonedMay 22, 03Jul 27, 06[C07H, C12P, C12N, C07K]
2006/0067,949 Immunization with porphyromonas gingivalis protects against heart diseaseAbandonedNov 18, 03Mar 30, 06[A61K]
7002345 Synthetic images for a magnetic resonance imaging scanner using linear combinations of source imagesExpiredMar 05, 04Feb 21, 06[G01V]
6917199 Synthetic images for a magnetic resonance imaging scanner using linear combination of source images to generate contrast and spatial navigationExpiredMar 05, 04Jul 12, 05[A61B, G01V]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.